CSF Beta2-Microglobulin in Diagnosis of CNS Leukemia or Lymphoma

Alex Y Chang, Kishan J. Pandya, Joe Rutledge, G. M. Mavligit

Research output: Contribution to journalLetter

Abstract

To the Editor: We read with interest the recent paper by Mavligit et al. in the September 25 issue. However, we would like to ask the following questions: How many patients were included in the analysis simply because of an elevation of cerebrospinal fluid (CSF) protein that was compatible with neurologic symptoms and signs? Would the P values for differences between the two groups of patients have reached a significant level if the analysis had considered only patients in whom Central-nervous-system (CNS) lymphoma or leukemia had been diagnosed through cytology of the CSF, brain biopsy, or post-mortem examination? The elevation.

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume304
Issue number6
DOIs
StatePublished - Feb 5 1981
Externally publishedYes

Fingerprint

Cerebrospinal Fluid
Lymphoma
Leukemia
Central Nervous System
Cerebrospinal Fluid Proteins
Neurologic Manifestations
Cell Biology
Autopsy
Biopsy
Brain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

CSF Beta2-Microglobulin in Diagnosis of CNS Leukemia or Lymphoma. / Chang, Alex Y; Pandya, Kishan J.; Rutledge, Joe; Mavligit, G. M.

In: New England Journal of Medicine, Vol. 304, No. 6, 05.02.1981.

Research output: Contribution to journalLetter

Chang, Alex Y ; Pandya, Kishan J. ; Rutledge, Joe ; Mavligit, G. M. / CSF Beta2-Microglobulin in Diagnosis of CNS Leukemia or Lymphoma. In: New England Journal of Medicine. 1981 ; Vol. 304, No. 6.
@article{20db7cd26a774be4bdf381e1bbc64e54,
title = "CSF Beta2-Microglobulin in Diagnosis of CNS Leukemia or Lymphoma",
abstract = "To the Editor: We read with interest the recent paper by Mavligit et al. in the September 25 issue. However, we would like to ask the following questions: How many patients were included in the analysis simply because of an elevation of cerebrospinal fluid (CSF) protein that was compatible with neurologic symptoms and signs? Would the P values for differences between the two groups of patients have reached a significant level if the analysis had considered only patients in whom Central-nervous-system (CNS) lymphoma or leukemia had been diagnosed through cytology of the CSF, brain biopsy, or post-mortem examination? The elevation.",
author = "Chang, {Alex Y} and Pandya, {Kishan J.} and Joe Rutledge and Mavligit, {G. M.}",
year = "1981",
month = "2",
day = "5",
doi = "10.1056/NEJM198102053040622",
language = "English (US)",
volume = "304",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "6",

}

TY - JOUR

T1 - CSF Beta2-Microglobulin in Diagnosis of CNS Leukemia or Lymphoma

AU - Chang, Alex Y

AU - Pandya, Kishan J.

AU - Rutledge, Joe

AU - Mavligit, G. M.

PY - 1981/2/5

Y1 - 1981/2/5

N2 - To the Editor: We read with interest the recent paper by Mavligit et al. in the September 25 issue. However, we would like to ask the following questions: How many patients were included in the analysis simply because of an elevation of cerebrospinal fluid (CSF) protein that was compatible with neurologic symptoms and signs? Would the P values for differences between the two groups of patients have reached a significant level if the analysis had considered only patients in whom Central-nervous-system (CNS) lymphoma or leukemia had been diagnosed through cytology of the CSF, brain biopsy, or post-mortem examination? The elevation.

AB - To the Editor: We read with interest the recent paper by Mavligit et al. in the September 25 issue. However, we would like to ask the following questions: How many patients were included in the analysis simply because of an elevation of cerebrospinal fluid (CSF) protein that was compatible with neurologic symptoms and signs? Would the P values for differences between the two groups of patients have reached a significant level if the analysis had considered only patients in whom Central-nervous-system (CNS) lymphoma or leukemia had been diagnosed through cytology of the CSF, brain biopsy, or post-mortem examination? The elevation.

UR - http://www.scopus.com/inward/record.url?scp=85023230657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023230657&partnerID=8YFLogxK

U2 - 10.1056/NEJM198102053040622

DO - 10.1056/NEJM198102053040622

M3 - Letter

C2 - 6160401

AN - SCOPUS:85023230657

VL - 304

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 6

ER -